Clinical Trials Browser

Terminated × vorolanib × Clear all

NCT04373369 2025-11-03

Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Phase 2 Terminated

11 enrolled 10 charts

Small Cell Lung Carcinoma

NCT03511222 2020-07-29

Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors

Phase 1 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Stomach Neoplasms